IPICK Blocking for TKA With Moderate Flexion Contracture

July 22, 2022 updated by: The First Hospital of Jilin University

IPICK Blocking for Extension Recovery in TKA With Preoperative Moderate Flexion Contracture

Clinical effect of intermittent multiple IPICK blocking on TKA for knee osteoarthritis with flexion contracture between 5 ° and 10 °

Study Overview

Detailed Description

From October 2020 to January 2021, 40 knee osteoarthritis patients with flexion contracture between 5 ° and 10 ° total knee arthroplasty are enrolled in this study. 20 patients are treated with Adductor Canal Block + Infiltration between the Popliteal Artery and Capsule of the Knee, and 20 patients are treated with Adductor Canal Block alone.

Study Type

Interventional

Enrollment (Actual)

42

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Changchun, China
        • The First Hospital of Jilin University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

50 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. The diagnosis was knee osteoarthritis
  2. The flexion contracture was between 5 and 10 degrees
  3. ASA grade I-III

Exclusion Criteria:

  1. Lower extremity neuropathy.
  2. Contraindications of nerve anesthesia or regional anesthesia.
  3. unable to cooperate, allergic to the drugs used in this study.
  4. Non steroidal anti-inflammatory drugs are not tolerated.
  5. chronic opioid consumption (daily or almost daily use)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: study group
The first 20 patients received Continue Adductor Canal Block + Infiltration between the Popliteal Artery and Capsule of the Knee
continue adductor canal block plus Infiltration between the Popliteal Artery and Capsule of the Knee
Sham Comparator: control group
The second 20 patients received Continue Adductor Canal Block alone
continue adductor canal block

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
evaluation of pain
Time Frame: 6 hours after surgery
Visual Analog Score for pain at rest, straightening, flexion at 45 ° and walking, the minimum and maximum values are 0 to 10, higher scores mean a worse outcome.
6 hours after surgery
evaluation of pain
Time Frame: postoperative day 1
Visual Analog Score for pain at rest, straightening, flexion at 45 ° and walking, the minimum and maximum values are 0 to 10, higher scores mean a worse outcome.
postoperative day 1
evaluation of pain
Time Frame: postoperative day 2
Visual Analog Score for pain at rest, straightening, flexion at 45 ° and walking, the minimum and maximum values are 0 to 10, higher scores mean a worse outcome.
postoperative day 2
evaluation of pain
Time Frame: postoperative day 3
Visual Analog Score for pain at rest, straightening, flexion at 45 ° and walking, the minimum and maximum values are 0 to 10, higher scores mean a worse outcome.
postoperative day 3
extension angle
Time Frame: before surgery
degree of the extension of knee
before surgery
extension angle
Time Frame: 0 hour after surgery
degree of the extension of knee
0 hour after surgery
extension angle
Time Frame: 6 hour after surgery
degree of the extension of knee
6 hour after surgery
extension angle
Time Frame: postoperative day 1
degree of the extension of knee
postoperative day 1
extension angle
Time Frame: postoperative day 2
degree of the extension of knee
postoperative day 2
extension angle
Time Frame: postoperative day 3
degree of the extension of knee
postoperative day 3

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
range of motion
Time Frame: 6 hour after surgery
degree of range of motion from extension to flexion of knee
6 hour after surgery
range of motion
Time Frame: postoperative day 1
degree of range of motion from extension to flexion of knee
postoperative day 1
range of motion
Time Frame: postoperative day 2
degree of range of motion from extension to flexion of knee
postoperative day 2
range of motion
Time Frame: postoperative day 3
degree of range of motion from extension to flexion of knee
postoperative day 3
opioid consumption
Time Frame: through hospitalization, an average of 7 days
total opioid consumption measured by milliliter.
through hospitalization, an average of 7 days
nerve block related symptoms
Time Frame: through hospitalization, an average of 7 days
the incidence of numbness of the nerve related skin
through hospitalization, an average of 7 days
postoperative acute pain
Time Frame: through hospitalization, an average of 7 days
number of cases whose Visual Analog Score for pain was more than 5
through hospitalization, an average of 7 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 1, 2020

Primary Completion (Actual)

February 28, 2021

Study Completion (Actual)

March 31, 2021

Study Registration Dates

First Submitted

October 8, 2020

First Submitted That Met QC Criteria

October 26, 2020

First Posted (Actual)

October 27, 2020

Study Record Updates

Last Update Posted (Actual)

July 26, 2022

Last Update Submitted That Met QC Criteria

July 22, 2022

Last Verified

October 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Knee Osteoarthritis

Clinical Trials on CACB+IPACK

3
Subscribe